Liposome-based nerve growth factor antisense therapy (University of Pittsburgh)

N/A

Report date: 2025/03/20 16:08:18
NME

Base Information

Drug NameLiposome-based nerve growth factor antisense therapy (University of Pittsburgh)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionBeta-nerve growth factor modulators
TargetsBeta-nerve growth factor
Therapy Area/IndicationsCystitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pittsburgh
Inactive CompaniesN/A
Active IndicationsCystitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A